×
Back to Agenda
Session 8, Track B: Next-Gen Pharmacovigilance: AI, NLP and Beyond
Session Chair(s)
Betty Duarte, PHARMD, MBA
Pharmacovigilance Director CAN & LATAM, Pfizer, Costa Rica
Lina Valero, MD, MBA, MSC
Regional PV Head LATAM, Opella Healthcare, Colombia
Learn how the AI and NLP are revolutionizing pharmacovigilance, enhancing drug safety monitoring, streamline case processing and enable predictive analytics or more accurate adverse event detection and signal management. Gain insights into the future of PV as we push beyond the traditional methods not next generation safety surveillance.
Learning Objective : - Describe how AI and NLP enhance adverse event detection, signal management, and risk assessment in pharmacovigilance
- Assess the potential of advanced technologies (machine learning, real world data analytics and automations) in transforming traditional pharmacovigilance processes
- Identify practical use cases where Ai and NLP can streamline case processing, improve data accuracy, enable predictive safety analytics in PV operations
Speaker(s)
Innovation In Pharmacovigilance: Strategies for Personalized Safety
Global Head Safety Risk Management, F Hoffmann-La Roche, Switzerland
Smart Pharmacovigilance: AI in Drug Safety
Regional PV Head LATAM, Opella Healthcare, Colombia
Artificial Intelligence for Pharmacovigilance
Specialist at Pharmacovigilance Officer (GFARM), ANVISA, Brazil
Have an account?